These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 30179845)
1. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats. Zhou J; Lei Y; Chen J; Zhou X Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845 [TBL] [Abstract][Full Text] [Related]
2. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats. Wu X; Gu Y; Li L Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977 [TBL] [Abstract][Full Text] [Related]
3. Potential ameliorative effects of grape seed-derived polyphenols against cadmium induced prostatic deficits. Lei Y; Chen Q; Chen J; Liu D Biomed Pharmacother; 2017 Jul; 91():707-713. PubMed ID: 28499242 [TBL] [Abstract][Full Text] [Related]
4. Potential Ameliorative Effects of Qing Ye Dan Against Cadmium Induced Prostatic Deficits via Regulating Nrf-2/HO-1 and TGF-β1/Smad Pathways. Du L; Lei Y; Chen J; Song H; Wu X Cell Physiol Biochem; 2017; 43(4):1359-1368. PubMed ID: 28992620 [TBL] [Abstract][Full Text] [Related]
5. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells. Hu S; Yu W; Lv TJ; Chang CS; Li X; Jin J Mol Membr Biol; 2014; 31(2-3):103-10. PubMed ID: 24650126 [TBL] [Abstract][Full Text] [Related]
6. Curcumin attenuates prostatic hyperplasia caused by inflammation Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837 [TBL] [Abstract][Full Text] [Related]
7. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688 [TBL] [Abstract][Full Text] [Related]
8. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway. Kim HJ; Jin BR; An HJ Biomed Pharmacother; 2023 Apr; 160():114389. PubMed ID: 36791565 [TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate attenuates transforming growth factor-β1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells. Wang Y; Liu N; Su X; Zhou G; Sun G; Du F; Bian X; Wang B Biomed Pharmacother; 2015 Mar; 70():260-7. PubMed ID: 25776510 [TBL] [Abstract][Full Text] [Related]
10. MIR663AHG as a competitive endogenous RNA regulating TGF-β-induced epithelial proliferation and epithelial-mesenchymal transition in benign prostate hyperplasia. Tong S; Mo M; Hu X; Wu L; Chen M; Zhao C J Biochem Mol Toxicol; 2023 Sep; 37(9):e23391. PubMed ID: 37518988 [TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis. Chen J; Du L; Li J; Song H Food Chem Toxicol; 2016 Oct; 96():70-8. PubMed ID: 27474435 [TBL] [Abstract][Full Text] [Related]
12. 2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1 Abdel-Naim AB; Neamatallah T; Eid BG; Esmat A; Alamoudi AJ; Abd El-Aziz GS; Ashour OM Oxid Med Cell Longev; 2018; 2018():4389484. PubMed ID: 30154949 [TBL] [Abstract][Full Text] [Related]
13. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145. Xiang Y; Zhang Y; Tang Y; Li Q Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533 [TBL] [Abstract][Full Text] [Related]
14. Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway. Wu T; Chen JM; Xiao TG; Shu XB; Xu HC; Yang LL; Xing LJ; Zheng PY; Ji G World J Gastroenterol; 2016 May; 22(19):4695-706. PubMed ID: 27217701 [TBL] [Abstract][Full Text] [Related]
15. Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats. Funahashi Y; Wang Z; O'Malley KJ; Tyagi P; DeFranco DB; Gingrich JR; Takahashi R; Majima T; Gotoh M; Yoshimura N Prostate; 2015 Mar; 75(4):381-9. PubMed ID: 25451715 [TBL] [Abstract][Full Text] [Related]
16. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2. Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799 [TBL] [Abstract][Full Text] [Related]
17. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development. Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828 [TBL] [Abstract][Full Text] [Related]
18. GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition. Kim Y; Lee D; Jo H; Go C; Yang J; Kang D; Kang JS Aging (Albany NY); 2021 Feb; 13(3):3202-3217. PubMed ID: 33539321 [TBL] [Abstract][Full Text] [Related]